The EU’s Drug Regulator Backed Eli Lilly’s Weight-Loss Pill. Here’s What Foundayo Has to Show on October 29

Key Stats for Eli Lilly StockCurrent Price: $1,257. 03Target Price (Mid): ~$2,216Street Target: ~$1,328Potential Total Return: ~76%Annualized IRR: ~14% / yearWhat Happened?Eli Lilly and Company (LLY) moved a step closer to selling its Foundayo weight-loss pill in the European Union on October 16.